Desikan SP, Ravandi F, Pemmaraju N, Konopleva M, et al. A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations. Acta Haematol 2022;145:529-536.
PMID: 35717939